Related Experiment Video
Updated: Jul 17, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Circulating Osteocalcin Fractions are Associated with Vascular Calcification and Mortality in Chronic Hemodialysis
Ruei-An Lin1,2, Jyh-Tong Hsieh3,4, Chin-Chou Huang1,5
1Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Insights
The percentage of carboxylated osteocalcin (%cOC) in plasma is linked to vascular calcification and predicts mortality in hemodialysis patients. Higher %cOC levels indicate increased risk, suggesting its use as a biomarker for chronic kidney disease-mineral and bone disorder.
Area of Science:
- Nephrology
- Biochemistry
- Cardiovascular Medicine
Background:
- Vascular calcification is common in end-stage kidney disease (ESKD) and linked to high mortality.
- The role of total osteocalcin (OC) in vascular calcification and mortality is unclear.
- Investigating specific OC fractions as biomarkers in ESKD is crucial.
Purpose of the Study:
- To determine if plasma osteocalcin fractions can predict vascular calcification and mortality in hemodialysis patients.
- To explore the association between plasma %cOC, vascular calcification, and parathyroid hormone (PTH).
Main Methods:
- Observational cohort study of 184 maintenance hemodialysis patients.
- Measurement of plasma carboxylated OC (cOC), uncarboxylated OC (ucOC), and intact PTH.
- Assessment of aortic calcification severity and three-year mortality follow-up.
Main Results:
- Plasma %cOC, not cOC or ucOC, was independently associated with vascular calcification severity.
- A U-shaped correlation was observed between plasma %cOC and PTH levels.
- Higher plasma %cOC levels were associated with a significantly increased risk of mortality.
Conclusions:
- Plasma %cOC is positively correlated with vascular calcification and exhibits a U-shaped correlation with PTH in hemodialysis patients.
- Elevated plasma %cOC levels predict increased mortality in this population.
- Plasma %cOC may serve as a valuable biomarker for CKD-mineral and bone disorder and a predictor of clinical outcomes.
Background:
Vascular calcification, a component of chronic kidney disease-mineral and bone disorder (CKD-MBD), is prevalent in patients with end-stage kidney disease (ESKD) and contributes to high mortality. However, the association between the blood level of total osteocalcin (OC) and vascular calcification and mortality remains inconclusive. We, therefore, investigated whether different OC fractions can serve as biomarkers of vascular calcification and mortality in the ESKD population.
Methods:
This observational cohort study enrolled patients on maintenance hemodialysis. Plasma carboxylated OC (cOC), uncarboxylated OC (ucOC), and intact parathyroid hormone (PTH) were measured. The percentage of carboxylated OC (%cOC) was calculated as dividing cOC by total OC. The vascular calcification severity was defined by an aortic calcification grade. The patients were followed for three years and one month.
Results:
A total of 184 patients were enrolled. In the multivariable logistic regression, plasma %cOC, but not cOC or ucOC, was independently associated with the severity of vascular calcification (OR 1.019, p = 0.036). A significant U-shaped correlation was found between plasma %cOC and PTH (p = 0.002). In the multivariable Cox regression, patients with higher plasma %cOC had a higher risk of mortality (quartiles Q4 versus Q1-Q3, HR 1.991 [95% CI: 1.036-3.824], p = 0.039).
Conclusions:
In patients undergoing chronic hemodialysis, plasma %cOC positively correlated with vascular calcification and exhibited a U-shaped correlation with PTH. Furthermore, a higher plasma %cOC was associated with increased mortality. These findings suggest that plasma %cOC may serve as a biomarker for CKD-MBD and a predictor of clinical outcomes in chronic hemodialysis patients.
Related Concept Videos
Skeleton and Calcium Homeostasis
Osteoclasts in Bone Remodeling
Chronic Kidney Disease II: Clinical Manifestations
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management

